Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reiberger

Showing results (141-150 of 491) with videos related to

Pageof 50
Sort By:
Journal of Virus Eradication|October 27, 2025
A liberalized approach to directly observed therapy for HCV retains excellent cure rates among PWID in ViennaCaroline Schwarz, Angelika Schütz, Maximilian Anibas, et al.
Alimentary Pharmacology & Therapeutics|May 27, 2024
Portal hypertension and its prognostic implications in patients with Wilson's diseaseLukas Burghart, Peter Ferenci, Oleksandr Petrenko, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2019
Hepatitis C Virus RNA Is Commonly Detectable in Rectal and Nasal Fluids of Patients With High ViremiaDavid Chromy, Ralf Schmidt, Mattias Mandorfer, et al.
The Journal of Infectious Diseases|May 22, 2010
Mitochondrial toxicity is associated with virological response in patients with HIV and hepatitis C virus coinfection treated with ribavirin and highly active antiretroviral therapyThomas Reiberger, Lana Kosi, Judith Maresch, et al.
Alimentary Pharmacology & Therapeutics|February 27, 2024
Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosisBenedikt Silvester Hofer, Lukas Burghart, Emina Halilbasic, et al.
Alimentary Pharmacology & Therapeutics|April 9, 2024
Editorial: Recompensation in PBC is good. But is it good enough? Authors' replyBenedikt Silvester Hofer, Lukas Burghart, Emina Halilbasic, et al.
Plos One|August 26, 2021
COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospitalKatharina Pomej, Bernhard Scheiner, Lukas Hartl, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 26, 2018
Erectile dysfunction in cirrhosis is impacted by liver dysfunction, portal hypertension, diabetes and arterial hypertensionRafael Paternostro, Birgit B Heinisch, Thomas Reiberger, et al.
Scientific Reports|May 17, 2024
Use of the CytoSorb adsorber in patients with acute-on-chronic liver failurePatrick Haselwanter, Bernhard Scheiner, Lorenz Balcar, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 12, 2024
Management of varices but not anticoagulation is associated with improved outcome in patients with HCC and macrovascular tumour invasionLorenz Balcar, Arpad Mrekva, Bernhard Scheiner, et al.
Pageof 50

Showing results (141-150 of 491) with videos related to

Sort By:
Pageof 50
Journal of Virus Eradication|October 27, 2025
A liberalized approach to directly observed therapy for HCV retains excellent cure rates among PWID in ViennaCaroline Schwarz, Angelika Schütz, Maximilian Anibas, et al.
Alimentary Pharmacology & Therapeutics|May 27, 2024
Portal hypertension and its prognostic implications in patients with Wilson's diseaseLukas Burghart, Peter Ferenci, Oleksandr Petrenko, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 29, 2019
Hepatitis C Virus RNA Is Commonly Detectable in Rectal and Nasal Fluids of Patients With High ViremiaDavid Chromy, Ralf Schmidt, Mattias Mandorfer, et al.
The Journal of Infectious Diseases|May 22, 2010
Mitochondrial toxicity is associated with virological response in patients with HIV and hepatitis C virus coinfection treated with ribavirin and highly active antiretroviral therapyThomas Reiberger, Lana Kosi, Judith Maresch, et al.
Alimentary Pharmacology & Therapeutics|February 27, 2024
Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosisBenedikt Silvester Hofer, Lukas Burghart, Emina Halilbasic, et al.
Alimentary Pharmacology & Therapeutics|April 9, 2024
Editorial: Recompensation in PBC is good. But is it good enough? Authors' replyBenedikt Silvester Hofer, Lukas Burghart, Emina Halilbasic, et al.
Plos One|August 26, 2021
COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospitalKatharina Pomej, Bernhard Scheiner, Lukas Hartl, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 26, 2018
Erectile dysfunction in cirrhosis is impacted by liver dysfunction, portal hypertension, diabetes and arterial hypertensionRafael Paternostro, Birgit B Heinisch, Thomas Reiberger, et al.
Scientific Reports|May 17, 2024
Use of the CytoSorb adsorber in patients with acute-on-chronic liver failurePatrick Haselwanter, Bernhard Scheiner, Lorenz Balcar, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 12, 2024
Management of varices but not anticoagulation is associated with improved outcome in patients with HCC and macrovascular tumour invasionLorenz Balcar, Arpad Mrekva, Bernhard Scheiner, et al.
Pageof 50